Publication Name	World Journal of Gastroenterology
Manuscript ID	78701
Country	India

Received	2022-07-10 14:19
Peer-Review Started	2022-07-10 14:21
To Make the First Decision
Return for Revision	2022-07-31 22:43
Revised	2022-08-04 17:39
Second Decision	2022-09-21 03:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-09-21 17:01
Articles in Press	2022-09-21 17:01
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-10-18 00:05
Typeset the Manuscript	2022-10-24 06:38
Publish the Manuscript Online	2022-10-28 12:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Management of liver diseases: Current perspectives
Manuscript Source	Invited Manuscript
All Author List	Gautam Ray
Funding Agency and Grant Number
Corresponding Author	Gautam Ray, Visiting Professor, MD, Academic Research, Chief Doctor, Doctor, Doctor, Teacher, Gastroenterology Unit, Department of Medicine, B.R.Singh (Railway) Hospital, Parikshit Roy Lane, Near Sealdah Bus Stop, Beliaghata, Kolkata 700014, West Bengal, India. gautam1910@yahoo.com
Key Words	Chronic liver disease; Genes; Biomarkers; Therapy; Hepatocellular carcinoma; Liver transplantation; Recent advances
Core Tip	The incidence and prevalence of liver disease is rising all over the world. Hepatitis B is difficult to eradicate and the benefit of directly acting antiviral therapy for hepatitis C is partially offset by increasing IV drug abuse. Non-alcoholic fatty liver disease pandemic is on and alcohol related liver disease is rising alarmingly, both having no drug cure. Due to better management of complications, patients of chronic liver disease are living longer spiking the number of hepatocellular carcinoma (HCC) and patients needing liver transplantation (LT). Better diagnostics and therapeutics are available for fibrosis, portal hypertension, HCC and post LT management which are discussed.
Publish Date	2022-10-28 12:37
Citation	Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol 2022; 28(40): 5818-5826
URL	https://www.wjgnet.com/1007-9327/full/v28/i40/5818.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i40.5818

Full Article (PDF)	WJG-28-5818.pdf
Full Article (Word)	WJG-28-5818.docx
Manuscript File	78701_Auto_Edited-Ma JY.docx
Answering Reviewers	78701-Answering reviewers.pdf
Audio Core Tip	78701-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	78701-Conflict-of-interest statement.pdf
Copyright License Agreement	78701-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	78701-Language certificate.pdf
Peer-review Report	78701-Peer-review(s).pdf
Scientific Misconduct Check	78701-Bing-Gao CC-2.png
Scientific Editor Work List	78701-Scientific editor work list.pdf
CrossCheck Report	78701-CrossCheck report.pdf